Lataa...
Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome
BACKGROUND: Hutchinson-Gilford progeria syndrome is an ultra-rare segmental premature aging disease resulting in early death from heart attack or stroke. There is no approved treatment, but starting in 2007, several recent single arm clinical trials have administered inhibitors of protein farnesylat...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4082404/ https://ncbi.nlm.nih.gov/pubmed/24795390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.113.008285 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|